NEU vs PYC

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

NEU

NEUREN FPO NZ [NEU]

43LOW

PYC

PYC THERAP FPO [PYC]

42LOW

Score Breakdown

NEU PYC
Technical
69
34
Catalyst
50
50
Sentiment
50
50
Fundamental
52
34
Momentum
22
54
Risk Gate
36
50

Key Metrics

NEU Metric PYC
$1.5BMarket Cap$1.2B
683KAvg Volume (20d)1.9M
+5.9%Short Interest+0.1%
$22.98552-Week High$1.755
$8.61052-Week Low$0.847
+0.1%Daily Change-2.9%
$11.945Entry Price$1.185
+8.7%ROE-47.5%
+47.1%Profit Margin-231.3%

Active Signals

NEU Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)

PYC Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Took a hit — down 10.9% over the last 5 days
Lagging the Small Ords index — relative strength of 0.88, underperforming its peers
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (7 quarters)

Ask Scout AI to compare NEU and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NEU Full Analysis → PYC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).